CRAd-S-pk7
AXP000052.1 · Oncolytic virus
- Platform
- adenovirus (Ad5, survivin promoter-driven E1A, polylysine (pk7) fiber)
- Originator
- Northwestern University
- Sponsor
- Northwestern University
Names
| Name | Type | Source |
|---|---|---|
| CRAd-S-pk7 | preferred name, code | curator, ncit |
| NSC-CRAd-S-pk7 | synonym | ncit |
| NSC-CRAd-Survivin-pk7 | synonym | ctgov |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5 (CRAd-S-pk7)
- Replication
- conditionally replicating
- Modifications
- survivin promoter drives E1A; polylysine (pk7) fiber modification
- Route
- intracerebral
- Carrier
- HB1.F3.CD neural stem cells
- Source
- evidence
Cross-references
- NCI Thesaurus
- C135612
Approvals
No regulatory approval recorded.
Clinical trials (3)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT06169280 | Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma | Active not recruiting | Phase 1 | 2025-06-27 | 2029-12-31 | 20 | Glioma, Malignant; New Diagnosis Tumor |
| NCT05139056 | Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas | Recruiting | Phase 1 | 2023-05-02 | 2028-02-07 | 36 | Currently Only Enrolling Glioblastoma Patients at First Recurrence |
| NCT03072134 | Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | Completed | Phase 1 | 2017-04-24 | 2020-04-06 | 12 | Anaplastic Astrocytoma; Anaplastic Oligoastrocytoma; Anaplastic Oligodendroglioma; Astrocytoma, Grade III; Astrocytoma, Grade IV; Brain Cancer; Glioblastoma Multiforme; Glioma |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 34214495 | Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. | The Lancet. Oncology | 2021 | cited by trial NCT03072134 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 42179969 | Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies. | Molecular therapy. Oncology | 2026 | name in title: CRAd-S-pk7 |
| PMID 42741068 | Treatment sequence of stem cell delivered heterologous oncolytic virus impact on tumor microenvironment in immunocompetent ovarian cancer model. | Frontiers in immunology | 2026 | name in abstract: NSC-CRAd-S-pk7 |
| PMID 33272983 | Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2021 | name in abstract: CRAd-S-pk7 |
| PMID 34944938 | Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of Glioblastoma. | Cancers | 2021 | name in abstract: NSC-CRAd-S-pk7 |
| PMID 30719498 | Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer. | Molecular therapy oncolytics | 2019 | name in abstract: CRAd-S-pk7 |
| PMID 27184224 | Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters. | Journal of translational medicine | 2016 | name in title: CRAd-S-pk7 |
| PMID 25525033 | Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction. | Cancer gene therapy | 2015 | name in abstract: NSC-CRAd-S-pk7 |
| PMID 22673390 | Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. | Gene therapy | 2013 | name in abstract: CRAd-S-pk7 |
| PMID 23883863 | N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy. | Molecular therapy : the journal of the American Society of Gene Therapy | 2013 | name in abstract: CRAd-S-pk7 |
| PMID 23926209 | The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma. | Stem cells translational medicine | 2013 | name in abstract: CRAd-S-pk7 |
| PMID 22555507 | Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. | Cancer gene therapy | 2012 | name in abstract: CRAd-S-pk7 |
| PMID 21629227 | Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. | Molecular therapy : the journal of the American Society of Gene Therapy | 2011 | name in abstract: CRAd-S-pk7 |
| PMID 20573677 | A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect. | Human reproduction (Oxford, England) | 2010 | name in title: CRAd-S-pk7 |
| PMID 19078993 | Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. | Gene therapy | 2009 | name in abstract: CRAd-S-pk7 |
| PMID 19277041 | Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. | British journal of cancer | 2009 | name in abstract: CRAd-S-pk7 |
| PMID 17630837 | Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. | Human gene therapy | 2007 | name in abstract: CRAd-S-pk7 |
| PMID 17016667 | Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. | International journal of oncology | 2006 | name in abstract: CRAd-S-pk7 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| P50CA221747 | Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma | NORTHWESTERN UNIVERSITY | LESNIAK, MACIEJ S | 2018–2022 | name in abstract: CRAd-S-pk7 |
| R01CA122930 | Conditionally Replicative Adenoviral Vectors for Malignant Glioma | UNIVERSITY OF CHICAGO | LESNIAK, MACIEJ S | 2008–2012 | name in abstract: CRAd-S-pk7 |
Notes
Delivered in HB1.F3.CD neural stem cells (NSC-CRAd-S-pk7) into the resection cavity in newly diagnosed malignant glioma, NCT03072134.
How to cite
CRAd-S-pk7 (AXP000052.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000052.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.